Search

Your search keyword '"Gee, Adrian P."' showing total 799 results
Start Over Author "Gee, Adrian P."
799 results on '"Gee, Adrian P."'

1. Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Author

Hegde, Meenakshi, Navai, Shoba, DeRenzo, Christopher, Joseph, Sujith K., Sanber, Khaled, Wu, Mengfen, Gad, Ahmed Z., Janeway, Katherine A., Campbell, Matthew, Mullikin, Dolores, Nawas, Zeid, Robertson, Catherine, Mathew, Pretty R., Zhang, Huimin, Mehta, Birju, Bhat, Raksha R., Major, Angela, Shree, Ankita, Gerken, Claudia, Kalra, Mamta, Chakraborty, Rikhia, Thakkar, Sachin G., Dakhova, Olga, Salsman, Vita S., Grilley, Bambi, Lapteva, Natalia, Gee, Adrian, Dotti, Gianpietro, Bao, Riyue, Salem, Ahmed Hamed, Wang, Tao, Brenner, Malcolm K., Heslop, Helen E., Wels, Winfried S., Hicks, M. John, Gottschalk, Stephen, and Ahmed, Nabil

Published
2024
Full Text
View/download PDF

2. Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury Insights Into the SENECA Trial

Author

O’Brien, Connor G, Ozen, Mehmet Ozgun, Ikeda, Gentaro, Vaskova, Evgeniya, Jung, Ji Hye, Bayardo, Nathan, Santoso, Michelle Rai, Shi, Liye, Wahlquist, Christine, Jiang, Zewen, Jung, Yunshin, Zeng, Yitian, Egan, Elizabeth, Sinclair, Robert, Gee, Adrian, Witteles, Ronald, Mercola, Mark, Svensson, Katrin J, Demirci, Utkan, and Yang, Phillip C

Subjects
Medical Biotechnology, Biomedical and Clinical Sciences, Cardiovascular, Regenerative Medicine, Clinical Research, Heart Disease, Stem Cell Research, Development of treatments and therapeutic interventions, 5.2 Cellular and gene therapies, anthracycline, cardiomyopathy, heart failure, AIC, anthracycline induced cardiomyopathy, DOX, doxorubicin, DZR, dexrazoxane, EV, extracellular vesicle, L-EV, large extracellular vesicle, MPP+, 1-methyl-4-phenylpyrindinium, MSC, mesenchymal stem cell, MSC-EV, mesenchymal stem cell derived extracellular vesicle, MTDR, MitoTracker Deep Red, MTG, MitoTracker Green, RBC, red blood cell, ROS, reactive oxygen species, S-EV, small extracellular vesicle, iCM, induced cardiomyocyte, Cardiovascular medicine and haematology, Oncology and carcinogenesis
Abstract

BackgroundAnthracycline-induced cardiomyopathy (AIC) is a significant source of morbidity and mortality in cancer survivors. The role of mesenchymal stem cells (MSCs) in treating AIC was evaluated in the SENECA trial, a Phase 1 National Heart, Lung, and Blood Institute-sponsored study, but the mechanisms underpinning efficacy in human tissue need clarification.ObjectivesThe purpose of this study was to perform an in vitro clinical trial evaluating the efficacy and putative mechanisms of SENECA trial-specific MSCs in treating doxorubicin (DOX) injury, using patient-specific induced pluripotent stem cell-derived cardiomyocytes (iCMs) generated from SENECA patients.MethodsPatient-specific iCMs were injured with 1 μmol/L DOX for 24 hours, treated with extracellular vesicles (EVs) from MSCs by either coculture or direct incubation and then assessed for viability and markers of improved cellular physiology. MSC-derived EVs were separated into large extracellular vesicles (L-EVs) (>200 nm) and small EVs (

Published
2021

15. A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial

Author

Bolli, Roberto, Mitrani, Raul D, Hare, Joshua M, Pepine, Carl J, Perin, Emerson C, Willerson, James T, Traverse, Jay H, Henry, Timothy D, Yang, Phillip C, Murphy, Michael P, March, Keith L, Schulman, Ivonne H, Ikram, Sohail, Lee, David P, O'Brien, Connor, Lima, Joao A, Ostovaneh, Mohammad R, Ambale‐Venkatesh, Bharath, Lewis, Gregory, Khan, Aisha, Bacallao, Ketty, Valasaki, Krystalenia, Longsomboon, Bangon, Gee, Adrian P, Richman, Sara, Taylor, Doris A, Lai, Dejian, Sayre, Shelly L, Bettencourt, Judy, Vojvodic, Rachel W, Cohen, Michelle L, Simpson, Lara, Aguilar, David, Loghin, Catalin, Moyé, Lem, Ebert, Ray F, Davis, Barry R, Simari, Robert D, and Network, for the Cardiovascular Cell Therapy Research

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Cardiovascular, Clinical Trials and Supportive Activities, Rehabilitation, Stem Cell Research, Clinical Research, Stem Cell Research - Nonembryonic - Human, Heart Disease, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Heart Failure, Humans, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Minnesota, Quality of Life, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Cell-based therapy, Clinical trial, Heart failure, Cardiovascular Cell Therapy Research Network, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology
Abstract

AimsCONCERT-HF is an NHLBI-sponsored, double-blind, placebo-controlled, Phase II trial designed to determine whether treatment with autologous bone marrow-derived mesenchymal stromal cells (MSCs) and c-kit positive cardiac cells (CPCs), given alone or in combination, is feasible, safe, and beneficial in patients with heart failure (HF) caused by ischaemic cardiomyopathy.Methods and resultsPatients were randomized (1:1:1:1) to transendocardial injection of MSCs combined with CPCs, MSCs alone, CPCs alone, or placebo, and followed for 12 months. Seven centres enrolled 125 participants with left ventricular ejection fraction of 28.6 ± 6.1% and scar size 19.4 ± 5.8%, in New York Heart Association class II or III. The proportion of major adverse cardiac events (MACE) was significantly decreased by CPCs alone (-22% vs. placebo, P = 0.043). Quality of life (Minnesota Living with Heart Failure Questionnaire score) was significantly improved by MSCs alone (P = 0.050) and MSCs + CPCs (P = 0.023) vs. placebo. Left ventricular ejection fraction, left ventricular volumes, scar size, 6-min walking distance, and peak oxygen consumption did not differ significantly among groups.ConclusionsThis is the first multicentre trial assessing CPCs and a combination of two cell types from different tissues in HF patients. The results show that treatment is safe and feasible. Even with maximal guideline-directed therapy, both CPCs and MSCs were associated with improved clinical outcomes (MACE and quality of life, respectively) in ischaemic HF without affecting left ventricular function or structure, suggesting possible systemic or paracrine cellular mechanisms. Combining MSCs with CPCs was associated with improvement in both these outcomes. These results suggest potential important beneficial effects of CPCs and MSCs and support further investigation in HF patients.

Published
2021

16. Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients The CCTRN SENECA Trial

Author

Bolli, Roberto, Perin, Emerson C, Willerson, James T, Yang, Phillip C, Traverse, Jay H, Henry, Timothy D, Pepine, Carl J, Mitrani, Raul D, Hare, Joshua M, Murphy, Michael P, March, Keith L, Ikram, Sohail, Lee, David P, O’Brien, Connor, Durand, Jean-Bernard, Miller, Kathy, Lima, Joao A, Ostovaneh, Mohammad R, Ambale-Venkatesh, Bharath, Gee, Adrian P, Richman, Sara, Taylor, Doris A, Sayre, Shelly L, Bettencourt, Judy, Vojvodic, Rachel W, Cohen, Michelle L, Simpson, Lara M, Lai, Dejian, Aguilar, David, Loghin, Catalin, Moyé, Lem, Ebert, Ray F, Davis, Barry R, Simari, Robert D, and Network, Cardiovascular Cell Therapy Research

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Oncology and Carcinogenesis, Cardiovascular, Clinical Research, Cancer, Heart Disease, Stem Cell Research, Clinical Trials and Supportive Activities, cardiac repair, cardiooncology, chemotherapy, heart failure, stem cells, Cardiovascular Cell Therapy Research Network, Cardiovascular medicine and haematology, Oncology and carcinogenesis
Abstract

BackgroundAnthracycline-induced cardiomyopathy (AIC) may be irreversible with a poor prognosis, disproportionately affecting women and young adults. Administration of allogeneic bone marrow-derived mesenchymal stromal cells (allo-MSCs) is a promising approach to heart failure (HF) treatment.ObjectivesSENECA (Stem Cell Injection in Cancer Survivors) was a phase 1 study of allo-MSCs in AIC.MethodsCancer survivors with chronic AIC (mean age 56.6 years; 68% women; NT-proBNP 1,426 pg/ml; 6 enrolled in an open-label, lead-in phase and 31 subjects randomized 1:1) received 1 × 108 allo-MSCs or vehicle transendocardially. Primary objectives were safety and feasibility. Secondary efficacy measures included cardiac function and structure measured by cardiac magnetic resonance imaging (CMR), functional capacity, quality of life (Minnesota Living with Heart Failure Questionnaire), and biomarkers.ResultsA total of 97% of subjects underwent successful study product injections; all allo-MSC-assigned subjects received the target dose of cells. Follow-up visits were well-attended (92%) with successful collection of endpoints in 94% at the 1-year visit. Although 58% of subjects had non-CMR compatible devices, CMR endpoints were successfully collected in 84% of subjects imaged at 1 year. No new tumors were reported. There were no significant differences between allo-MSC and vehicle groups with regard to clinical outcomes. Secondary measures included 6-min walk test (p = 0.056) and Minnesota Living with Heart Failure Questionnaire score (p = 0.048), which tended to favor the allo-MSC group.ConclusionsIn this first-in-human study of cell therapy in patients with AIC, transendocardial administration of allo-MSCs appears safe and feasible, and CMR was successfully performed in the majority of the HF patients with devices. This study lays the groundwork for phase 2 trials aimed at assessing efficacy of cell therapy in patients with AIC.

Published
2020

18. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

Author

Steffin, David H.M., Muhsen, Ibrahim N., Hill, LaQuisa C., Ramos, Carlos A., Ahmed, Nabil, Hegde, Meenakshi, Wang, Tao, Wu, Mengfen, Gottschalk, Stephen, Whittle, Sarah B., Lulla, Premal D., Mamonkin, Maksim, Omer, Bilal, Rouce, Rayne H., Heczey, Andras, Metelitsa, Leonid S., Grilley, Bambi J., Robertson, Catherine, Torrano, Virginia, Lapteva, Natalia, Gee, Adrian P., Rooney, Cliona M., Brenner, Malcolm K., and Heslop, Helen E.

Published
2022
Full Text
View/download PDF

19. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Author

Lulla, Premal D., Naik, Swati, Vasileiou, Spyridoula, Tzannou, Ifigeneia, Watanabe, Ayumi, Kuvalekar, Manik, Lulla, Suhasini, Carrum, George, Ramos, Carlos A., Kamble, Rammurti, Hill, LaQuisa, Randhawa, Jasleen, Gottschalk, Stephen, Krance, Robert, Wang, Tao, Wu, Mengfen, Robertson, Catherine, Gee, Adrian P., Chung, Betty, Grilley, Bambi, Brenner, Malcolm K., Heslop, Helen E., Vera, Juan F., and Leen, Ann M.

Published
2021
Full Text
View/download PDF

32. Regulation of Regenerative Medicine Products

Author

Gee, Adrian P., COHEN, IRUN R., Series Editor, LAJTHA, ABEL, Series Editor, LAMBRIS, JOHN D., Series Editor, PAOLETTI, RODOLFO, Series Editor, Rezaei, Nima, Series Editor, Schmuck, Eric G., editor, Hematti, Peiman, editor, and Raval, Amish N., editor

Published
2018
Full Text
View/download PDF

38. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Author

Ramos, Carlos A., Rouce, Rayne, Robertson, Catherine S., Reyna, Amy, Narala, Neeharika, Vyas, Gayatri, Mehta, Birju, Zhang, Huimin, Dakhova, Olga, Carrum, George, Kamble, Rammurti T., Gee, Adrian P., Mei, Zhuyong, Wu, Meng-Fen, Liu, Hao, Grilley, Bambi, Rooney, Cliona M., Heslop, Helen E., Brenner, Malcolm K., Savoldo, Barbara, and Dotti, Gianpietro

Published
2018
Full Text
View/download PDF

42. Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

Author

Hegde, Meenakshi, Joseph, Sujith K., Pashankar, Farzana, DeRenzo, Christopher, Sanber, Khaled, Navai, Shoba, Byrd, Tiara T., Hicks, John, Xu, Mina L., Gerken, Claudia, Kalra, Mamta, Robertson, Catherine, Zhang, Huimin, Shree, Ankita, Mehta, Birju, Dakhova, Olga, Salsman, Vita S., Grilley, Bambi, Gee, Adrian, Dotti, Gianpietro, Heslop, Helen E., Brenner, Malcolm K., Wels, Winfried S., Gottschalk, Stephen, and Ahmed, Nabil

Published
2020
Full Text
View/download PDF

43. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Author

Galipeau, Jacques, Krampera, Mauro, Barrett, John, Dazzi, Francesco, Deans, Robert J., DeBruijn, Joost, Dominici, Massimo, Fibbe, Willem E., Gee, Adrian P., Gimble, Jeffery M., Hematti, Peiman, Koh, Mickey B.C., LeBlanc, Katarina, Martin, Ivan, McNiece, Ian K., Mendicino, Michael, Oh, Steve, Ortiz, Luis, Phinney, Donald G., Planat, Valerie, Shi, Yufang, Stroncek, David F., Viswanathan, Sowmya, Weiss, Daniel J., and Sensebe, Luc

Published
2016
Full Text
View/download PDF

44. Contributors

Author

Abdel-Wahab, Omar, primary, Abrahm, Janet L., additional, Adams, Sharon, additional, Adewoye, Adeboye H., additional, Allen, Carl, additional, Ambinder, Richard F., additional, Anasetti, Claudio, additional, Anastasi, John, additional, Anderson, Julia A., additional, Antin, Joseph H., additional, Antony, Aśok C., additional, Araten, David J., additional, Armand, Philippe, additional, Armstrong, Gillian, additional, Armstrong, Scott A., additional, Arnold, Donald M., additional, Artz, Andrew S., additional, Awan, Farrukh T., additional, Baglin, Trevor P., additional, Benson, Don M., additional, Benz, Edward J., additional, Berliner, Nancy, additional, Bhagat, Govind, additional, Bhardwaj, Nina, additional, Bhatia, Ravi, additional, Bhatia, Smita, additional, Bhatt, Mihir D., additional, Bhatt, Vijaya Raj, additional, Bitan, Menachem, additional, Blinderman, Craig D., additional, Bollard, Catherine M., additional, Braun, Benjamin S., additional, Brenner, Malcolm K., additional, Brittenham, Gary M., additional, Brodsky, Robert A., additional, Brown, Myles, additional, Broxmeyer, Hal E., additional, Brummel-Ziedins, Kathleen, additional, Brunner, Andrew M., additional, Buadi, Francis K., additional, Burkhardt, Birgit, additional, Burns, Melissa, additional, Byrd, John C., additional, Caimi, Paolo F., additional, Caligiuri, Michael A., additional, Canavan, Michelle, additional, Cantor, Alan B., additional, Carcao, Manuel, additional, Carroll, Michael C., additional, Carty, Shannon A., additional, Castillo, Jorge J., additional, Chan, Anthony K.C., additional, Chapin, John, additional, Chiu, April, additional, Chute, John P., additional, Clark, David B., additional, Coates, Thomas D., additional, Cogle, Christopher R., additional, Connell, Nathan T., additional, Cooke, Elizabeth, additional, Cooley, Sarah, additional, Corradini, Paolo, additional, Creager, Mark A., additional, Creger, Richard J., additional, Cromwell, Caroline, additional, Crowther, Mark A., additional, Cushing, Melissa M., additional, Cutler, Corey, additional, Dang, Chi V., additional, Danial, Nika N., additional, Dave, Sandeep S., additional, DeCaprio, James A., additional, Dinauer, Mary C., additional, Dinner, Shira, additional, Diz-Küçükkaya, Reyhan, additional, Dodd, Roger Y., additional, Donato, Michele L., additional, Dorshkind, Kenneth, additional, Dotti, Gianpietro, additional, Dror, Yigal, additional, Dunleavy, Kieron, additional, Dvorak, Christopher C., additional, Ebert, Benjamin L., additional, Eck, Michael J., additional, Eikelboom, John W., additional, Epperla, Narendranath, additional, Ershler, William B., additional, Evans, William E., additional, Faderl, Stefan, additional, Ferrara, James L.M., additional, Filipovich, Alexandra Hult, additional, Fischer, Martin, additional, Fredenburgh, James C., additional, Friedman, Kenneth D., additional, Fuchs, Ephraim, additional, Fuller, Stephen J., additional, Gailani, David, additional, Galipeau, Jacques, additional, Gallagher, Patrick G., additional, Ganapathi, Karthik A., additional, Gardner, Lawrence B., additional, Gee, Adrian P., additional, Gerson, Stanton L., additional, Gertz, Morie A., additional, Giardina, Patricia J., additional, Gibson, Christopher J., additional, Golan, Karin, additional, Golub, Todd R., additional, Gonzales, Matthew J., additional, Gotlib, Jason, additional, Gottschalk, Stephen, additional, Grant, Marianne A., additional, Graubert, Timothy A., additional, Gregg, Xylina T., additional, Gribben, John G., additional, Gross, Dawn M., additional, Gruber, Tanja A., additional, Guitart, Joan, additional, Gurbuxani, Sandeep, additional, Gur-Cohen, Shiri, additional, Gutierrez, Alejandro, additional, Hamadani, Mehdi, additional, Hari, Parameswaran N., additional, Hartwig, John H., additional, Hayman, Suzanne R., additional, Hayward, Catherine P.M., additional, Hebbel, Robert P., additional, Heslop, Helen E., additional, Hillis, Christopher, additional, Hillyer, Christopher D., additional, Ho, Karin, additional, Hockenbery, David M., additional, Hoffman, Ronald, additional, Hogg, Kerstin E., additional, Holtan, Shernan G., additional, Horny, Hans-Peter, additional, Hsu, Yen-Michael S., additional, Hunter, Zachary R., additional, Huntington, James A., additional, Iancu-Rubin, Camelia, additional, Iqbal, Ali, additional, Isenman, David E., additional, Israels, Sara J., additional, Italiano, Joseph E., additional, Jaffe, Elaine S., additional, Jaffer, Iqbal H., additional, Jagannath, Sundar, additional, Jäger, Ulrich, additional, Jain, Nitin, additional, James, Paula, additional, Jeha, Sima, additional, Jordan, Michael B., additional, Josephson, Cassandra D., additional, Jung, Moonjung, additional, Kager, Leo, additional, Kambayashi, Taku, additional, Kanakry, Jennifer A., additional, Kantarjian, Hagop M., additional, Kaplan, Jason, additional, Karafin, Matthew S., additional, Karsan, Aly, additional, Kaufman, Randal J., additional, Kaufman, Richard M., additional, Keller, Frank G., additional, Kelly, Kara M., additional, Kessler, Craig M., additional, Key, Nigel S., additional, Keyzner, Alla, additional, Khandoga, Alexander G., additional, Khanna-Gupta, Arati, additional, Khatib-Massalha, Eman, additional, Klein, Harvey G., additional, Knoechel, Birgit, additional, Kollet, Orit, additional, Konkle, Barbara A., additional, Kontoyiannis, Dimitrios P., additional, Koreth, John, additional, Koretzky, Gary A., additional, Kotecha, Dipak, additional, Kremyanskaya, Marina, additional, Kumari, Anju, additional, Kuzel, Timothy M., additional, Küppers, Ralf, additional, Lacy, Martha Q., additional, Ladas, Elana, additional, Landier, Wendy, additional, Lapid, Kfir, additional, Lapidot, Tsvee, additional, Larson, Peter J., additional, Levi, Marcel, additional, Lewis, Russell E., additional, Liebman, Howard A., additional, Lillicrap, David, additional, Lim, Wendy, additional, Lin, Judith C., additional, Lindblad, Robert, additional, Lip, Gregory Y.H., additional, Little, Jane A., additional, Lohr, Jens G., additional, López, José A., additional, Luscinskas, Francis W., additional, Maciejewski, Jaroslaw P., additional, Majhail, Navneet S., additional, Manches, Olivier, additional, Mandle, Robert J., additional, Mann, Kenneth G., additional, Manno, Catherine S., additional, Marcogliese, Andrea N., additional, Mariani, Guglielmo, additional, Marincola, Francesco M., additional, Mascarenhas, John, additional, Massberg, Steffen, additional, McEver, Rodger P., additional, McGrath, Emer, additional, McKinney, Matthew S., additional, Mehta, Rohtesh S., additional, Mentzer, William C., additional, Merlini, Giampaolo, additional, Merryman, Reid, additional, Michel, Marc, additional, Migliaccio, Anna Rita, additional, Miller, Jeffrey S., additional, Mims, Martha P., additional, Mondoro, Traci Heath, additional, Moorehead, Paul, additional, Muniz, Luciana R., additional, Munshi, Nikhil C., additional, Najfeld, Vesna, additional, Nayak, Lalitha, additional, Nazy, Ishac, additional, Neff, Anne T., additional, Ness, Paul M., additional, Notarangelo, Luigi D., additional, O'Brien, Sarah H., additional, O'Connor, Owen A., additional, O'Donnell, Martin, additional, Olson, Amanda, additional, Orkin, Stuart H., additional, Pai, Menaka, additional, Pai, Sung-Yun, additional, Paidas, Michael, additional, Panch, Sandhya R., additional, Pande, Reena L., additional, Papayannopoulou, Thalia, additional, Parikh, Rahul, additional, Petersdorf, Effie W., additional, Peterson, Shane E., additional, Pittaluga, Stefania, additional, Ponce, Doris M., additional, Popolo, Laura, additional, Prchal, Josef T., additional, Pui, Ching-Hon, additional, Puigserver, Pere, additional, Rak, Janusz, additional, Ramos, Carlos A., additional, Rand, Jacob H., additional, Rand, Margaret L., additional, Rao, Dinesh S., additional, Ravandi, Farhad, additional, Rawlings, David J., additional, Reddy, Pavan, additional, Reding, Mark T., additional, Reiter, Andreas, additional, Rice, Lawrence, additional, Riese, Matthew J., additional, Ritchey, Arthur Kim, additional, Roberts, David J., additional, Roman, Elizabeth, additional, Rooney, Cliona M., additional, Rosen, Steven T., additional, Rosenthal, David S., additional, Rossmann, Marlies P., additional, Rot, Antal, additional, Rowley, Scott D., additional, Rubnitz, Jeffrey E., additional, Rydz, Natalia, additional, Salama, Mohamed E., additional, Sauk, Steven, additional, Saunthararajah, Yogen, additional, Savage, William, additional, Scadden, David, additional, Schaefer, Kristen G., additional, Schiffman, Fred, additional, Schneidewend, Robert, additional, Schrier, Stanley L., additional, Schuchman, Edward H., additional, Scullion, Bridget Fowler, additional, Selvaggi, Kathy J., additional, Senoo, Keitaro, additional, Shaheen, Montaser, additional, Shaz, Beth H., additional, Shelburne, Samuel A., additional, Shpall, Elizabeth J., additional, Shurin, Susan B., additional, Siegal, Deborah, additional, Silberstein, Leslie E., additional, Silberstein, Lev, additional, Silverstein, Roy L., additional, Sloan, Steven R., additional, Smith, Franklin O., additional, Smith, James W., additional, Smith, Katy, additional, Steensma, David P., additional, Steinberg, Martin H., additional, Stock, Wendy, additional, Storry, Jill R., additional, Stramer, Susan L., additional, Strauss, Ronald G., additional, Stroncek, David F., additional, Taylor, Justin, additional, Thota, Swapna, additional, Treon, Steven P., additional, Tulpule, Anil, additional, Valdes, Roberto Ferro, additional, Valent, Peter, additional, Vedantham, Suresh, additional, Vercellotti, Gregory M., additional, Verneris, Michael R., additional, Vichinsky, Elliott P., additional, von Andrian, Ulrich H., additional, Vose, Julie M., additional, Wagner, Andrew J., additional, Wang, Ena, additional, Wang, Jia-huai, additional, Warkentin, Theodore E., additional, Wasserstein, Melissa P., additional, Webster, Ann, additional, Weisdorf, Daniel J., additional, Weitz, Jeffrey I., additional, Westhoff, Connie M., additional, Wheeler, Allison P., additional, Widick, Page, additional, Wiley, James S., additional, William, Basem M., additional, Williams, David A., additional, Wilson, Wyndham H., additional, Wolfe, Joanne, additional, Wolgast, Lucia R., additional, Wood, Deborah, additional, Wu, Jennifer, additional, Yahalom, Joachim, additional, Yee, Donald L., additional, Younes, Anas, additional, Young, Neal S., additional, and Zeller, Michelle P., additional

Published
2018
Full Text
View/download PDF

46. Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

Author

Lapteva, Natalia, primary, Gilbert, Margaret, primary, Diaconu, Iulia, primary, Rollins, Lisa A., primary, Al-Sabbagh, Mina, primary, Naik, Swati, primary, Krance, Robert A., primary, Tripic, Tamara, primary, Hiregange, Manasa, primary, Raghavan, Darshana, primary, Dakhova, Olga, primary, Rouce, Rayne H., primary, Liu, Hao, primary, Omer, Bilal, primary, Savoldo, Barbara, primary, Dotti, Gianpietro, primary, Cruz, Conrad Russel, primary, Sharpe, Keli, primary, Gates, Melissa, primary, Orozco, Aaron, primary, Durett, April, primary, Pacheco, Elizabeth, primary, Gee, Adrian P., primary, Ramos, Carlos A., primary, Heslop, Helen E., primary, Brenner, Malcolm K., primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

Author

Lapteva, Natalia, primary, Gilbert, Margaret, primary, Diaconu, Iulia, primary, Rollins, Lisa A., primary, Al-Sabbagh, Mina, primary, Naik, Swati, primary, Krance, Robert A., primary, Tripic, Tamara, primary, Hiregange, Manasa, primary, Raghavan, Darshana, primary, Dakhova, Olga, primary, Rouce, Rayne H., primary, Liu, Hao, primary, Omer, Bilal, primary, Savoldo, Barbara, primary, Dotti, Gianpietro, primary, Cruz, Conrad Russel, primary, Sharpe, Keli, primary, Gates, Melissa, primary, Orozco, Aaron, primary, Durett, April, primary, Pacheco, Elizabeth, primary, Gee, Adrian P., primary, Ramos, Carlos A., primary, Heslop, Helen E., primary, Brenner, Malcolm K., primary, and Rooney, Cliona M., primary

Published
2023
Full Text
View/download PDF

49. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

Author

Zhou, Xiaoou, Dotti, Gianpietro, Krance, Robert A., Martinez, Caridad A., Naik, Swati, Kamble, Rammurti T., Durett, April G., Dakhova, Olga, Savoldo, Barbara, Di Stasi, Antonio, Spencer, David M., Lin, Yu-Feng, Liu, Hao, Grilley, Bambi J., Gee, Adrian P., Rooney, Cliona M., Heslop, Helen E., and Brenner, Malcolm K.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results